Arda Durmaz

发表

Measuring competitive exclusion in non-small cell lung cancer

Jacob G. Scott, A. Marusyk, M. Hitomi, 2022, bioRxiv.

Dose dependent evolutionary game dynamics modulate competitive release in cancer therapy

Jacob G. Scott, A. Marusyk, M. Hitomi, 2020 .

Identifying States of Collateral Sensitivity during the Evolution of Therapeutic Resistance in Ewing's Sarcoma

Jacob G. Scott, P. Anderson, S. Lessnick, 2020, iScience.

Identifying states of collateral sensitivity during the evolution of therapeutic resistance in Ewing’s sarcoma

Jacob G. Scott, P. Anderson, S. Lessnick, 2020 .

Development and characterization of patient-derived xenografts from non-small cell lung cancer brain metastases

I. Ong, A. Baschnagel, R. Kimple, 2020, Scientific Reports.

TP53 mutations in endometrial cancer contribute to clinically-relevant radiation resistance and highlight the potential for biomarker-driven radiosensitization strategies

R. Vargas, O. Reizes, R. Debernardo, 2022, bioRxiv.

Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

J. Soulier, E. Clappier, M. Voso, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Friend or foe? The case of Wilms' Tumor 1 (WT1) mutations in acute myeloid leukemia.

V. Visconte, H. Awada, Arda Durmaz, 2021, Blood cells, molecules & diseases.

Stability of scRNA-Seq Analysis Workflows is Susceptible to Preprocessing and is Mitigated by Regularized or Supervised Approaches

Arda Durmaz, J. Scott, A. Durmaz, 2022, Evolutionary bioinformatics online.

A study of Telomerase Reverse Transcriptase rare variants in myeloid neoplasia

T. Haferlach, J. Maciejewski, V. Visconte, 2022, Hematological oncology.

Variability in scRNA-Seq analysis is mitigated by regularized or supervised approaches

Jacob G. Scott, Arda Durmaz, A. Durmaz, 2021, bioRxiv.

Measuring competitive exclusion in non–small cell lung cancer

Jacob G. Scott, A. Marusyk, M. Hitomi, 2020, bioRxiv.

Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures

Jacob G. Scott, A. Tan, Mingxiang Teng, 2020, Nature Communications.

Are the current guidelines for identification of myelodysplastic syndrome with germline predisposition strong enough?

F. Solé, J. Maciejewski, Oriol Calvete, 2023, British journal of haematology.

Target-Independent Prediction of Drug Synergies Using Only Drug Lipophilicity

Frederick P. Roth, Cem Meydan, Ivan Iossifov, 2014, J. Chem. Inf. Model..

Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes

V. Visconte, H. Awada, Arda Durmaz, 2022, International journal of molecular sciences.

A multimodal analysis of genomic and RNA splicing features in myeloid malignancies

T. Haferlach, J. Barnard, J. Maciejewski, 2023, iScience.

Impact of immediate cryopreservation on the establishment of patient derived xenografts from head and neck cancer patients

Jacob G. Scott, A. Baschnagel, D. Wheeler, 2020, Journal of Translational Medicine.

Frequency-dependent ecological interactions increase the prevalence and shape the distribution of pre-existing drug resistance

Christopher D. McFarland, M. Hinczewski, Jeff Maltas, 2023, bioRxiv.